General Information
CinCor HTN
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group, Dose Finding Study to Evaluate the Efficacy and Safety of 2 Doses of CIN-107 as Compares With Placebo After 12 Weeks of Treatment in Patients with Treatment-Resistant Hypertension (rHTN)
| Protocol | CIN-107-121 |
|---|---|
| Identifier | |
| UID | 733a8892-b4bb-4185-81a3-8526882af4ba |
| Status | PI Declined |
| Phase | 2 |
| Category | Hypertension / Adult |
| Launch Year | 2020 |
| NCT Number | - |
| Created | 2020-04-14 12:41 |
| Last Updated | 2020-04-14 12:41 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | No | |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohseni, Rizwana | RMohseni | No |
| Recruiter | Mireles, Eddie | EMireles | No |
| Coordinator | Valenzuela, Louisito | LValenzuela | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | CinCor Pharma, Inc |
|---|---|
| Division | CinCor Pharma, Inc |
| Team | CinCor Pharma, Inc |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Medpace, Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gray |
| Currency | - |
